Please wait ...

Karry Smith, PhD, MPH


Dr. Karry Smith earned a Master of Public Health (MPH) degree and a PhD in Cell Biology from the University of Iowa. She has worked in the pharmaceutical industry since 2014 and is currently a Medical Writing Manager at Greenwich Biosciences, the company that makes the FDA-approved, cannabinoid-based product Epidiolex. In 2019, Dr. Smith earned a graduate certificate in cannabinoid pharmacology from Thomas Jefferson University in Philadelphia.


Dr. Smith has longstanding interests in pain medicine, addiction, opioids, and cannabinoids. To that end, she is currently pursuing a Doctor of Public Health (DrPH) degree at Johns Hopkins in Health Policy and Management and hopes to focus her research on pain and the safety of cannabinoids co-administered with opioids. She is passionate about education and is currently co-teaching a special topics course to healthcare students at Des Moines University that focuses on pain management and associated issues.

Dr. Smith is an employee of Greenwich Biosciences/GW Pharma.  She was previously (withing the past 12 months) a paid consultant for MedPharm Iowa, a state-licensed medical cannabis manufacturer.

Dr. Smith discloses that he has no relevant financial relationships with any organization producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.

 

Product Type
On Demand

Chronic Pain


Total Credits: 2 including 2 AOA Category 1-A Credit(s)

Average Rating:
   4.6
Faculty:
Jolene Smith, DO |  Karry Smith, PhD, MPH
Short Description:
The goal of this lecture is to understand the evolution of pain management, treatment with opioids, overdose epidemic, and currently accepted be practices for treating patients.
Price:
$80.00 - Base Price

Showing 1 to 1 of 1 entries